USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION

A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no va...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHANG, Stanley, LAI, Kuan-lang
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	CHANG, Stanley LAI, Kuan-lang
description	A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided. La présente invention concerne l'utilisation d'oligosaccharides sulfatés dans la fabrication d'un médicament permettant de réduire la récurrence d'une tumeur intrahépatique et d'accroître la période de survie sans maladie chez un patient atteint d'un carcinome hépatocellulaire (HCC) présentant une invasion microvasculaire après résection hépatique curative, tout en excluant les patients atteints d'HCC sans invasion vasculaire et les patients atteints d'HCC présentant une invasion macrovasculaire.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2018157762A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2018157762A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2018157762A13</originalsourceid><addsrcrecordid>eNqNjUFqwzAQRb3JoiS9w0DWgTqldbbDeGQJZKmMRnhpTFBWITUkB8mRK0oP0NXjfx7_vzTPnBiigZS9QeUeondDTEhkUVzPCVwAtQwjhmyQNMuvjzBy7whHDgomCqgwqgsDfFXUMsHk1ILlmiOx99mjAKGQC3FEQKMs9VaGuuJBODGpi2HXbC7L9V5e_7ht9oaV7KGs33O5r8u53MpjnuLxrT21H133ecT2_X_WDz45QYY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION</title><source>esp@cenet</source><creator>CHANG, Stanley ; LAI, Kuan-lang</creator><creatorcontrib>CHANG, Stanley ; LAI, Kuan-lang</creatorcontrib><description>A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided. La présente invention concerne l'utilisation d'oligosaccharides sulfatés dans la fabrication d'un médicament permettant de réduire la récurrence d'une tumeur intrahépatique et d'accroître la période de survie sans maladie chez un patient atteint d'un carcinome hépatocellulaire (HCC) présentant une invasion microvasculaire après résection hépatique curative, tout en excluant les patients atteints d'HCC sans invasion vasculaire et les patients atteints d'HCC présentant une invasion macrovasculaire.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180907&DB=EPODOC&CC=WO&NR=2018157762A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180907&DB=EPODOC&CC=WO&NR=2018157762A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHANG, Stanley</creatorcontrib><creatorcontrib>LAI, Kuan-lang</creatorcontrib><title>USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION</title><description>A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided. La présente invention concerne l'utilisation d'oligosaccharides sulfatés dans la fabrication d'un médicament permettant de réduire la récurrence d'une tumeur intrahépatique et d'accroître la période de survie sans maladie chez un patient atteint d'un carcinome hépatocellulaire (HCC) présentant une invasion microvasculaire après résection hépatique curative, tout en excluant les patients atteints d'HCC sans invasion vasculaire et les patients atteints d'HCC présentant une invasion macrovasculaire.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUFqwzAQRb3JoiS9w0DWgTqldbbDeGQJZKmMRnhpTFBWITUkB8mRK0oP0NXjfx7_vzTPnBiigZS9QeUeondDTEhkUVzPCVwAtQwjhmyQNMuvjzBy7whHDgomCqgwqgsDfFXUMsHk1ILlmiOx99mjAKGQC3FEQKMs9VaGuuJBODGpi2HXbC7L9V5e_7ht9oaV7KGs33O5r8u53MpjnuLxrT21H133ecT2_X_WDz45QYY</recordid><startdate>20180907</startdate><enddate>20180907</enddate><creator>CHANG, Stanley</creator><creator>LAI, Kuan-lang</creator><scope>EVB</scope></search><sort><creationdate>20180907</creationdate><title>USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION</title><author>CHANG, Stanley ; LAI, Kuan-lang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2018157762A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHANG, Stanley</creatorcontrib><creatorcontrib>LAI, Kuan-lang</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHANG, Stanley</au><au>LAI, Kuan-lang</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION</title><date>2018-09-07</date><risdate>2018</risdate><abstract>A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided. La présente invention concerne l'utilisation d'oligosaccharides sulfatés dans la fabrication d'un médicament permettant de réduire la récurrence d'une tumeur intrahépatique et d'accroître la période de survie sans maladie chez un patient atteint d'un carcinome hépatocellulaire (HCC) présentant une invasion microvasculaire après résection hépatique curative, tout en excluant les patients atteints d'HCC sans invasion vasculaire et les patients atteints d'HCC présentant une invasion macrovasculaire.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2018157762A1
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A59%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHANG,%20Stanley&rft.date=2018-09-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2018157762A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true